Pan-Cancer Prediction of Radiotherapy Benefit Using Genomic-Adjusted Radiation Dose
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Lancet Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Pan-Cancer Prediction of Radiotherapy Benefit Using Genomic-Adjusted Radiation Dose (GARD): A Cohort-Based Pooled Analysis
Lancet Oncol 2021 Aug 04;[EPub Ahead of Print], JG Scott, G Sedor, P Ellsworth, JA Scarborough, KA Ahmed, DE Oliver, SA Eschrich, MW Kattan, JF Torres-RocaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.